Gout
Remains under-treated
Higher success when pharmacists and RNs manage ULT
Abs 2220, 1247, 1272
Roundup – Cush, Kavanaugh #ACR18 @RheumNow

— D White (@WIRheum) October 24, 2018

What’s in a name. Gout by any other name may be better treated. All hail Urate Crystal Arthritis#ACR18@RheumNow Abstract268 pic.twitter.com/iGEENPJM85

— William Shergy (@WilliamShergy) October 21, 2018

Abstract 2220: gout flares and allopurinol use population study. Unfortunately, gout is *vastly* undertreated. Similar abstracts 1247, 1272 show that pharmacist driven gout care can work well #ACR18 pic.twitter.com/09A85ehnf1

— Dr. Paul Sufka (@psufka) October 24, 2018

#ACR18 poster 1265:
Gout management in primary care can be improved with a thoughtful structured approach. Quantity and quality of ULT improves; proportion failing to meet SUA target fell from 64% to 39%. Exemplary approach to gout care. @RheumNow pic.twitter.com/GeE5RRU0Pr

— ǝlʇʇıɥʍ ɯɐs (@samwhittle) October 22, 2018

Dr. Cush
ABSTRACT: 2220
Gout, Flares and Allopurinol Use: A Population Based Study. —Australian study, large number of under treated with rate lowering therapy. Also, see abstracts: 1247, 1272. #ACR18 @Rheumnowhttps://t.co/BJKqxFtuvG

— Suleman Bhana, MD (@DrBhana) October 24, 2018